An observational, prospective study to assess the use, effectiveness, and safety of voxelotor in patients with sickle cell disease (SCD) in a real-life setting (VoxEval)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/1000000186
• EU PAS number:
  EUPAS1000000186
• Study ID:
  1000000186
• Official title and acronym:
  An observational, prospective study to assess the use, effectiveness, and safety of voxelotor in patients with sickle cell disease (SCD) in a real-life setting (VoxEval)
• DARWIN EU® study:
  No
• Study countries:
  France
• Study status:
  Cancelled

Study timelines

Date when funding contract was signed

Actual: 31/07/2023

Study start date

Planned: 15/10/2024

Date of final study report

Planned: 31/12/2030

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable